comparemela.com

Latest Breaking News On - Indraprastha medical corporation - Page 1 : comparemela.com

Indraprastha Standalone March 2024 Net Sales at Rs 314 73 crore, up 14 84% Y-o-Y

Indraprastha Standalone March 2024 Net Sales at Rs 314 73 crore, up 14 84% Y-o-Y
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

Indraprastha medical corporationReported standaloneNet profit

Indraprastha Medical Corporation Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024

Indraprastha Medical Corporation Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 3,147.3 million.

Indraprastha medical corporationIndraprastha medical corporation limited

Bulk deals: Quant Small Cap Fund picks up stake in Indraprastha Medical

Indraprastha Medical Corporation is a joint venture between Apollo Hospitals and the Delhi Government

New delhiVinsys it services indiaNav capital emerging star fundZinnia global fund pccMinerva ventures fundCell dewcap fundIndraprastha medical corporationQuant small cap fundNova global opportunities fund pccBofa securities europeApollo hospitalsDewcap fundNav capital vccCapital emerging starNav capitalBulk deals

Moneycontrol Pro Market Outlook | Can Nifty touch 23,000 this week?

This week s spotlight was on energy and gold, both experiencing significant price movements. The benchmark indices traded near the all-time highs, small stocks had a free run

Canara bankIndraprastha medical corporationPage industriesApar industriesFederal reserveDow jonesReserve bankDay exponential moving averageBest agrolifeOnmobile globalEuro stoxxIndus towersBata india

Broader indices outperformance continue; 400 smallcap stocks give double digit return

The recent consolidation in Nifty amid weak global cues indicates time-wise correction and traders should maintain a positive bias until the Nifty holds 22,200 level, sayd Ajit Mishra, SVP - Technical Research, Religare Broking.

Tamil naduJatin gediaVinod nairThemis biosynOswal greentechAndrew yuleAshapura minechemLloyds enterprisesHead of researchTechnical research analyst at sharekhanEnergy servicesArchean chemical industriesMarathon nextgen realtyBank niftyNifty realtyIndraprastha medical corporation

vimarsana © 2020. All Rights Reserved.